Tenax Therapeutics: A Speculative Buy

2026-01-09 01:51:30 ET

My Approach to Pick Biotech Stocks

Being acutely aware of the risks of investing in the notoriously risky biotech space, as a non-scientist, I have developed the following apparently simple but actually tough three criteria for picking life science stocks:

First , the company must have a late-stage asset that either has been approved by the FDA or is very likely to be approved in the foreseeable future....

Read the full article on Seeking Alpha

For further details see: